Virtues and woes of AChE alternative splicing in stress-related neuropathologies

Trends in Neurosciences
E Meshorer, Hermona Soreq

Abstract

The ACh hydrolyzing enzyme acetylcholinesterase (AChE) is a combinatorial series of proteins with variant N and C termini generated from alternate promoter usage and 3' alternative splicing. Neuronal AChE variants show indistinguishable enzymatic activity yet differ in their expression, multimeric assembly and membrane-association patterns. Differentially induced under stress, they show distinct non-hydrolytic properties and interact with different protein partners. Recent findings suggest that transcriptional and post-transcriptional regulation of AChE pre-mRNA is a neuroprotection strategy but might involve long-term damage. Specifically, variant-specific causal involvement of AChE in the progression of both neurodegenerative diseases (e.g. Alzheimer's and Parkinson's diseases) and neuromuscular syndromes (e.g. myasthenia gravis) raises the possibility that future therapeutic drugs might target specific AChE variant(s) or the corresponding RNA transcripts.

References

Jan 18, 1980·Science·S M AntelmanD Kocan
Apr 1, 1995·Current Opinion in Neurobiology·T G Aigner
Jan 1, 1994·Annual Review of Pharmacology and Toxicology·P Taylor, Z Radić
Jan 1, 1995·Experimental Brain Research·R Metherate, J H Ashe
Jul 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·M SternfeldH Soreq
Aug 10, 2000·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·E ShohamiH Soreq
Apr 3, 2001·Nature Reviews. Neuroscience·H Soreq, S Seidman
Apr 20, 2001·The New England Journal of Medicine·D R Weinberger
Apr 21, 2001·Psychopharmacology·A CiameiC Castellano
Jan 24, 2002·Neuron·Anselme L PerrierEric Krejci
Sep 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·N V ChandrasekharanDaniel L Simmons
Dec 20, 2002·DNA and Cell Biology·Peter StoilovStefan Stamm
Jan 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Klara R BirikhHermona Soreq
Jan 30, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Talma BrennerHermona Soreq
Feb 4, 2003·Nature Reviews. Neuroscience·Sultan DarveshChangiz Geula
Apr 11, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·E Jon Popke
Jul 29, 2003·Aging Cell·Eran Meshorer, Hermona Soreq
Dec 17, 2003·Pharmacopsychiatry·A Ströhle, F Holsboer
Dec 23, 2003·The European Journal of Neuroscience·Audrée PinardRichard Robitaille
Apr 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ella H SklanHermona Soreq
Apr 17, 2004·Cancer Research·Sang Eun ParkYoung Hyun Yoo
May 5, 2004·The Journal of Biological Chemistry·Eran MeshorerHermona Soreq
Aug 12, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Marco RacchiStefano Govoni
Aug 24, 2004·Nature Reviews. Neuroscience·Martin Citron
Sep 2, 2004·Nature Reviews. Molecular Cell Biology·Chanseok Shin, James L Manley
Oct 16, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Haiheng DongWei-Yang Lu
Nov 13, 2004·Nature·Jürgen SoutschekHans-Peter Vornlocher

❮ Previous
Next ❯

Citations

Dec 4, 2013·International Journal of Biological Macromolecules·Jana JanockovaMaria Kozurkova
Nov 10, 2013·International Journal of Cell Biology·Maurizio RomanoDiana Baralle
Aug 13, 2013·BioMed Research International·Maria Giulia LionettoTrifone Schettino
Dec 10, 2013·Journal of Molecular Neuroscience : MN·María-Letizia CampanariJavier Sáez-Valero
Dec 12, 2013·Journal of Molecular Neuroscience : MN·Katarina GrosTomaz Mars
Feb 28, 2014·Journal of Molecular Neuroscience : MN·Huang-Quan LinChi-Cheong David Wan
Nov 19, 2013·Journal of Molecular Neuroscience : MN·María Fernanda MontenegroCecilio J Vidal
Sep 5, 2008·PloS One·Debra ToiberHermona Soreq
Aug 28, 2009·Journal of Molecular Neuroscience : MN·Ari MeersonDaniela Kaufer
Jan 24, 2013·Drug Design, Development and Therapy·Corrado AngeliniMichela Bisciglia
Jun 28, 2011·Arhiv za higijenu rada i toksikologiju·Anita BosakZrinka Kovarik
Sep 19, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Caridad López-GraneroFernando Sánchez-Santed
Jan 23, 2008·Biological Chemistry·María F MontenegroCecilio J Vidal
Jul 28, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Keren OfekBente K Pedersen
Aug 1, 2013·Journal of Photochemistry and Photobiology. B, Biology·Rui MorgadoSusana Loureiro
Jun 28, 2006·Cell and Tissue Research·Gabriel Zimmerman, Hermona Soreq
Aug 30, 2008·The Journal of Cell Biology·Eran Meshorer
Jun 28, 2007·Expert Opinion on Investigational Drugs·Jochen Klein
Feb 10, 2011·Scandinavian Journal of Clinical and Laboratory Investigation·Ronan M G BergKirsten Møller
Feb 26, 2016·Neuroscience and Biobehavioral Reviews·Anand GururajanJohn F Cryan
Dec 3, 2015·International Journal of Radiation Biology·Paola ValbonesiElena Fabbri
Oct 18, 2011·Toxicology Letters·G RamaRao, B K Bhattacharya
Jul 16, 2010·Archives of Oral Biology·T L NandasenaC D Nanayakkara
Dec 25, 2015·Journal of Molecular Neuroscience : MN·Beatriz E García-GómezCecilio J Vidal
Mar 8, 2016·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·André Felipe RodriguesAngela T S Wyse
Jun 10, 2008·Trends in Neurosciences·Takumi Takizawa, Eran Meshorer
Oct 26, 2007·Brain, Behavior, and Immunity·Irit Shapira-LichterRaz Yirmiya
Mar 24, 2007·Life Sciences·Amir DoriItzhak Wirguin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Alzheimer's Disease: Transcription

Impaired transcription is associated with the pathogenesis and progression of conditions such as Alzheimer's disease (AD). Here are the latest discoveries pertaining to transcription and AD.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.